GENUS Stimulation for Alzheimer Disease and Healthy Adults
Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)
Recruiting
Phase 2
Interventional Study
Cognitively Healthy People
Alzheimer Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Massachusetts Institute of Technology · Other
Who this trial is looking for
This trial is looking for cognitively healthy adults to evaluate the effects of a new device called GENUS, which uses light and sound stimulation. Participants will spend one day at MIT for testing that includes brain scans and psychological assessments.
Are You a Good Fit for This Trial?
You may be able to join if
- I have good vision and hearing.
- I can follow instructions for tests and study procedures.
You may not be able to join if
- I have a history of seizures or a diagnosis of epilepsy.
- I cannot have an MRI due to metal implants or devices.
- The site investigator believes I cannot complete the study procedures.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in slowing cognitive impairment is not only revolutionary but also possibly cost- effective. In this study…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Have adequate visual and auditory acuity for visual and auditory stimulation to allow for neuropsychological testing.
* Be able to comply with neuropsychological testing and other study procedures in opinion of site PI.
Exclusion Criteria: Participants will be screened for th…
Contacts